Lipella Pharmaceuticals Inc Share Price

NASDAQ: LIPO

$0.60

-1.76

(-74.58%)

Live

as on September 16, 2025 at 12:47 am IST

$₹

The stock has been delisted from the stock exchange on 18 Jun 2025

Lipella Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 12:47 am IST

Day's Low
Day's High
$0.66
Day's Price Range
$0.66
$0.6
-10.00%
Downside
10.00%
Upside
52 Week's Low
52 Week's High
$1.97
52-Week Price Range
$7.31
$0.6
-227.50%
Downside
1118.33%
Upside

Lipella Pharmaceuticals Inc share price movements today

Previous Close: $2.36
Open: $0.66
Volume: 1.0K
Day's Low - High: $0.66 - $0.66
52 Week Low - High: $1.97 - $7.31

Lipella Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Lipella Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Lipella Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Lipella Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Lipella Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lipella Pharmaceuticals Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Lipella Pharmaceuticals Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Lipella Pharmaceuticals Inc. Average target price of $10

Lipella Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Lipella Pharmaceuticals Inc.

What analysts predicted

94%UPSIDE

Target Price

$10

Current Price

$0.6

Analyzed by

7 Analysts

Target

$10.00

Lipella Pharmaceuticals Inc target price $10, a slight upside of 94% compared to current price of $0.6. According to 7 analysts rating.

Lipella Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	0	106	104	0	0	0	0	0	129
Gross Profit	0	0	105	103	0	0	0	0	0	129
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	0	-1	-1	-1	0	-1	0	-1	-1	-1,306
Net Profit Margin	-240.25%	-904.57%	-1.44%	-1.27%	-570.07%	-816.98%	-687.63%	-1797.26%	-830.14%	-1009.76%

Lipella Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0
Gross Profit	0	0	-1	-2	-2	-3
Operating Income	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-
Net Income	0	0	-1	-2	-4	-5
Net Profit Margin	-8.90%	-6.91%	-719.30%	-1409.71%	-1027.31%	-935.25%

Global Institutional Holdings in Lipella Pharmaceuticals Inc

Funds	Holdings
Tower Research Capital LLC	0.06%
Mccormack Advisors International	0%
Bank of America Corp	0%
Virtu Financial LLC	0%

About Lipella Pharmaceuticals Inc

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. The Company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The Company is addressing two indications via the development of its product candidates, which it has designated as LP-10 for the indication of hemorrhagic cystitis (HC) and LP-310 for the indication of oral lichen planus (OLP), which is chronic, uncontrolled urinary blood loss that results from certain chemotherapies (such as alkylating agents) or pelvic radiation therapy (also called radiation cystitis). In the third program, the Company is also developing an oral, liposomal formulation of tacrolimus, LP-410, for the treatment of oral graft-versus-host disease (GVHD). In a fourth program, the Company is also developing an intravesical formulation of immunoglobulins including checkpoint inhibitors, referred to as LP-50.

Organisation	Lipella Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Lipella Pharmaceuticals Inc share price today?

Lipella Pharmaceuticals Inc share price today is $0.6 as on September 16, 2025 at 12:47 am IST. Lipella Pharmaceuticals Inc share today touched a day high of $0.66 and a low of $0.66.

What is the 52 week high and 52 week low for Lipella Pharmaceuticals Inc share?

Lipella Pharmaceuticals Inc share touched a 52 week high of $7.31 on February 6, 2025 and a 52 week low of $1.97 on April 9, 2025. Lipella Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 12:47 am IST is trending at $0.6,which is 91.79% down from its 52 week high and -69.47% up from its 52 week low.

How to invest in Lipella Pharmaceuticals Inc Stock (LIPO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lipella Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lipella Pharmaceuticals Inc Shares that will get you 2.5000 shares as per Lipella Pharmaceuticals Inc share price of $0.6 per share as on September 16, 2025 at 12:47 am IST.

What is the minimum amount required to buy Lipella Pharmaceuticals Inc Stock (LIPO) from India?

Indian investors can start investing in Lipella Pharmaceuticals Inc (LIPO) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 1:00 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Lipella Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 1:00 am IST). Based on Lipella Pharmaceuticals Inc share’s latest price of $0.6 as on September 16, 2025 at 12:47 am IST, you will get 16.6667 shares of Lipella Pharmaceuticals Inc. Learn more about fractional shares .